Drugs & Targets EMA validates application for BMS’s Opdivo + Yervoy for unresectable or advanced HCC July 26, 2024Vol.50 No.30
Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.” July 19, 2024Vol.50 No.29By Jacquelyn Cobb
U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage dataRankings now include a list of Best Regional Hospitals for Equitable Access July 19, 2024Vol.50 No.29By Matthew Bin Han Ong
Health EquityWhite House Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa July 19, 2024Vol.50 No.29By McKenzie Prillaman
Health Equity Proposed rule by CMS would expand access to cancer treatment at tribal facilities July 19, 2024Vol.50 No.29By Jacquelyn Cobb
In Brief Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute July 19, 2024Vol.50 No.29
In Brief Jennifer Munson named director of Fralin Biomedical Research Institute at VTC’s Cancer Research Center July 19, 2024Vol.50 No.29
In Brief Monica Bertagnolli and Brett Guthrie named Friends 2024 Cancer Leadership Award recipients July 19, 2024Vol.50 No.29
In Brief Vapiwala, Wright, Ng, Corso, Siker elected to ASTRO’s board of directors July 19, 2024Vol.50 No.29
